CVS Stock Risk & Deep Value Analysis
CVS Health Corp
Healthcare • Healthcare Plans
DVR Score
out of 10
What You Need to Know About CVS Stock
We analyzed CVS Health Corp using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran CVS through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Moderate. Here's what we found.
CVS Risk Analysis & Red Flags
What Could Go Wrong
The biggest risk for CVS is the ongoing and escalating regulatory and legal scrutiny on its PBM operations, coupled with adverse legislative actions at state and federal levels. This could lead to significant financial penalties, forced operational changes that compress margins further, and hinder its ability to leverage its integrated model for growth, potentially causing a sustained stock price decline as investor confidence erodes.
Risk Matrix
Overall
Moderate
Financial
Low
Market
Medium
Competitive
Medium
Execution
Medium
Regulatory
High
Red Flags
- ⚠
New racketeering class-action lawsuit impacting stock (-7% over 30 days)
- ⚠
Tennessee PBM legislation threatening store closures, indicating broader legislative risk
- ⚠
Medicare Advantage rates for 2027 (0.09%) lagging expectations, impacting a key growth segment
- ⚠
Trailing P/E of 56x significantly above industry and peer averages (18.3x-23x)
Upcoming Risk Events
- 📅
New racketeering class-action lawsuit on PBM operations (ongoing legal risk)
- 📅
Tennessee PBM legislation and national legal challenges (regulatory pressure)
- 📅
Further adverse Medicare Advantage rate adjustments for 2027 and beyond
- 📅
Omnicare bankruptcy process and integration risks
When to Reconsider
- 🚪
Exit if multiple new PBM-related class-action lawsuits emerge or significant federal legislation passes severely limiting PBM profitability.
- 🚪
Sell if full-year revenue guidance is revised downwards to negative growth.
- 🚪
Consider reducing exposure if net margin falls below 0.25% for two consecutive quarters, indicating severe margin pressure.
Unlock CVS Risk Analysis & Red Flags
Create a free account to see the full analysis
What Does CVS Health Corp (CVS) Do?
Market Cap
$98.34B
Sector
Healthcare
Industry
Healthcare Plans
Employees
219,000
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
Visit CVS Health Corp WebsiteInvestment Thesis
CVS Health is a robust, integrated healthcare services provider offering stable dividends and defensive characteristics within the vast U.S. healthcare market. Its strategic acquisitions and ongoing operational efficiencies aim to capture a larger share of healthcare spending. While not a 10x growth candidate, it represents a moderate-risk investment for long-term capital preservation and income, with potential for modest appreciation driven by successful integration, regulatory clarity, and consistent earnings.
Is CVS Stock Undervalued?
Unlock the full AI analysis for CVS
Get the complete DVR score, risk analysis, and more
Unlock the full report
Create a free account to see the DVR score, risk flags, and AI analysis.
CVS Price Targets & Strategy
12-Month Target
$95.00
Bull Case
$110.00
Bear Case
$65.00
Valuation Basis
Based on 16x forward P/E applied to the midpoint of FY26 EPS guidance ($6.04) = $96.64. Adjusted to $95 based on analyst consensus and regulatory headwinds.
Entry Strategy
Consider accumulation on dips towards the $70-$75 range, leveraging any market overreactions to negative news. Current price ~$77.30 is near recent support levels. Dollar-cost averaging is appropriate for a stable, dividend-paying stock.
Exit Strategy
Profit-taking could begin around the $95-$100 analyst price target range. A stop-loss order at $70 could limit downside risk, representing a break below recent lows and increasing regulatory pressure.
Portfolio Allocation
2-4% for moderate risk tolerance, primarily for income and defensive stability rather than growth.
Price Targets & Strategy
Upgrade to Premium for price targets and entry/exit strategies
Is CVS Financially Healthy?
Valuation
P/E Ratio
55.62
Forward P/E
10.50
Profitability
Gross Margin
13.77%
Operating Margin
1.28%
Net Margin
0.44%
Return on Equity
2.34%
Revenue Growth
7.85%
EPS
$1.37
Balance Sheet
Current Ratio
0.84
Quick Ratio
0.63
Debt/Equity
0.86
Cash Flow
Operating Cash Flow
$10.60B
Other
Beta (Volatility)
0.53
Dividend Yield
3.46%
Does CVS Have a Competitive Moat?
Sign in to unlockMoat Rating
🛡️ Narrow
Moat Trend
Stable
Moat Sources
4 Identified
CVS's moat derives from its vast integrated scale, enabling cost advantages and network effects across its various segments (PBM, retail, insurance, care delivery). Switching costs for large institutional clients and individual consumers within its ecosystem also contribute. However, its moat is consistently challenged by intense competition, regulatory scrutiny, and evolving healthcare models.
Moat Erosion Risks
- •Government legislation directly targeting PBM practices, eroding profitability and market power.
- •Increased competitive pressure from tech giants (Amazon, Walmart) entering pharmacy and healthcare services.
- •Loss of major health plan or employer group PBM contracts due to price competition or regulatory changes.
CVS Competitive Moat Analysis
Sign up to see competitive advantages
CVS Market Intelligence
Sentiment & Insider Activity
Social Sentiment
Neutral, mixed views dominated by discussions on healthcare costs and regulatory actions rather than hyper-growth potential.
Institutional Sentiment
Neutral to Positive. 'Moderate Buy' consensus from analysts, with some recent upgrades (Baird target raise, Wells Fargo 'Overweight'), yet institutional sales (Lbp Am Sa sold 19,605 shares) indicate mixed conviction.
Insider Activity (Form 4)
No specific Form 4 filings from executive insiders (CEO/CFO) detailed in the last 90 days. Institutional sale by Lbp Am Sa (19,605 shares on April 16, 2026) is noted.
Options Flow
Normal options activity. No specific unusual put/call ratio or large block trades indicating strong institutional directional bets mentioned.
Earnings Intelligence
Next Earnings
2026-05-06
Surprise Probability
Medium. CVS has a history of beating EPS estimates (Q4 2025 beat by $0.09), but Q1 2026 revenue estimate shows a slight YoY decline, and EPS consensus varies significantly ($2.19 vs. $1.00 alternative).
Historical Earnings Pattern
CVS stock often sees moderate movement (typically +/- 2-5%) on earnings, with larger swings tied to guidance updates or significant news regarding regulatory environments or M&A integration.
Key Metrics to Watch
Competitive Position
Top Competitor
UNH
Market Share Trend
Stable to slightly gaining through strategic acquisitions, but facing competitive pressures in retail pharmacy and PBM sectors from large players like UnitedHealth and new entrants like Amazon/Walmart.
Valuation vs Peers
Trading at a significant premium on trailing P/E (56x vs. peers 18.3x-23x), but at a discount on forward P/E (11.1x vs. industry 15.51x) and PEG (0.83 vs. industry 1.39), suggesting expectations for future earnings growth or current EPS is depressed by non-recurring items.
Competitive Advantages
- •Integrated healthcare ecosystem (PBM, pharmacy, insurance, primary care)
- •Massive retail footprint and brand recognition
- •Scale and bargaining power within the healthcare supply chain
Market Intelligence
Get sentiment, earnings intel, and peer analysis with Premium
What Could Drive CVS Stock Higher?
Near-Term (0-6 months)
- •Q1 2026 Earnings Call on May 6, 2026
- •Resolution of FTC insulin pricing complaints (regulatory tailwind)
- •Progress on Oak Street Health and Signify Health integration synergies
Medium-Term (6-18 months)
- •Further expansion of integrated healthcare services offerings (e.g., Aetna, MinuteClinic, Oak Street)
- •Stabilization of Medicare Advantage rates beyond 2027
- •Successful navigation of PBM legislative challenges
Long-Term (18+ months)
- •Successful transformation into a comprehensive health solutions company, deepening patient relationships
- •Industry-wide shift towards value-based care models benefiting integrated providers
- •Expansion of in-home care services with Signify Health's reach
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for CVS?
- ✓
Consistent positive free cash flow generation and debt reduction
- ✓
Successful resolution of key PBM legal challenges and stability in regulatory environment
- ✓
Accelerated growth in Oak Street Health and Signify Health segments
Bull Case Analysis
See what could go right with Premium
Competing with CVS
See how CVS Health Corp compares to related companies
| Company | Market Cap | DVR Score | P/E | Revenue | Profit Margin | Rev Growth | |
|---|---|---|---|---|---|---|---|
CVS Health Corp CVS | $98.3B | 0.2 | 55.6 | $402.1B | 0.4% | 7.8% | |
AbbVie Inc ABBV | $403.8B | 0.1 | 171.8 | — | — | — | Compare → |
Johnson & Johnson JNJ | — | 1.0 | — | — | — | — | Compare → |
Eli Lilly and Co LLY | $965.0B | 0.5 | 52.6 | — | — | — | Compare → |
Pfizer Inc PFE | $150.6B | 0.2 | 19.4 | $62.6B | 12.4% | -1.6% | Compare → |
UnitedHealth Group Inc UNH | $276.2B | 0.3 | 22.9 | $113.7B | 2.7% | 1181.0% | Compare → |
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
How CVS Health Corp Makes Money
CVS Health operates as a diversified healthcare company, primarily making money through three segments: Pharmacy Services (managing prescription drug benefits for health plans, employers, and government programs), Retail/LTC (operating retail pharmacies, MinuteClinic walk-in clinics, and long-term care pharmacies), and Health Care Benefits (providing health insurance services through Aetna). Its business model focuses on integrating these offerings to provide a comprehensive healthcare ecosystem, aiming to improve patient outcomes while controlling costs across the continuum of care.
Read Full Business Model BreakdownFAQ
What is the DVR Score for CVS Health Corp (CVS)?
As of April 19, 2026, CVS Health Corp has a DVR Score of 0.2 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What is the market capitalization of CVS Health Corp?
CVS Health Corp's market capitalization is approximately $98.3B. The company operates in the Healthcare sector within the Healthcare Plans industry.
What ticker symbol does CVS Health Corp use?
CVS is the ticker symbol for CVS Health Corp. The company trades on the NYQ.
What is the risk level for CVS stock?
Our analysis rates CVS Health Corp's overall risk as Moderate. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
What is the P/E ratio of CVS?
CVS Health Corp currently has a price-to-earnings (P/E) ratio of 55.6. This is above the market average, suggesting the stock may be priced for high growth expectations.
Does CVS Health Corp pay a dividend?
Yes, CVS Health Corp pays a dividend with a current yield of approximately 3.46%.
Is CVS Health Corp's revenue growing?
CVS Health Corp has reported revenue growth of 7.8%. The company is growing at a moderate pace.
Is CVS stock profitable?
CVS Health Corp has a profit margin of 0.4%. The company is profitable but margins are modest.
How often is the CVS DVR analysis updated?
Our AI-powered analysis of CVS Health Corp is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on April 19, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for CVS (CVS Health Corp) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.